A detailed history of Bok Financial Private Wealth, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Bok Financial Private Wealth, Inc. holds 20 shares of MRNA stock, worth $1,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$1,315
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$69.51 - $104.43 $1,390 - $2,088
20 New
20 $1,000
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $146,763 - $221,267
-1,253 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $17,451 - $32,436
138 Added 12.38%
1,253 $216,000
Q4 2021

Feb 15, 2022

SELL
$225.82 - $368.51 $14,000 - $22,847
-62 Reduced 5.27%
1,115 $283,000
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $261,176 - $570,221
1,177 New
1,177 $452,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bok Financial Private Wealth, Inc. Portfolio

Follow Bok Financial Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bok Financial Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bok Financial Private Wealth, Inc. with notifications on news.